House Committee Approves Measure to Reauthorize FDA User Fees
- May 20, 2022
The House Energy and Commerce Committee advanced May 18 legislation (H.R. 7667) to reauthorize Food and Drug Administration (FDA) user fees, which are set to expire September 30.
ARTICLE TAGS
You must be logged in to access this content.